International Company For Medical Industries S.A.E. (EGX:FCMD)
Egypt · Delayed Price · Currency is EGP 7.05
0.00 (0.00%)
At close: Sep 8, 2026
EGX:FCMD Cash Flow Statement
Financials in millions EGP. Fiscal year is January - December.
Millions EGP. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 2.84 | -19.73 | 1.51 | 0.92 | -0.09 | 0.03 |
Depreciation & Amortization | 2.27 | 1.47 | 3.39 | 0.83 | 0.83 | 0.83 |
Loss (Gain) From Sale of Assets | - | - | -12.35 | - | -0.25 | - |
Other Operating Activities | 16.59 | 27.77 | -1.09 | -0.05 | 0.04 | -0.02 |
Change in Accounts Receivable | -12.17 | -4.19 | 1.66 | -8 | 0.68 | 0.1 |
Change in Inventory | -0.8 | -5.71 | -3.45 | -6.1 | 0.08 | -1.25 |
Change in Accounts Payable | 16.64 | 6.73 | 1.69 | 2.22 | -0.09 | 0.1 |
Change in Income Taxes | -1.03 | - | 0.96 | - | - | - |
Change in Other Net Operating Assets | -22.97 | 14.91 | 23.43 | -10.65 | -2.27 | -1.15 |
Operating Cash Flow | 2.35 | 21.24 | 15.76 | -20.83 | -1.08 | -1.35 |
Operating Cash Flow Growth | -85.11% | 34.80% | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Capital Expenditures | -0.34 | -10.25 | - | -0.9 | - | - |
Sale of Property, Plant & Equipment | - | - | 11.96 | - | 1.32 | - |
Investing Cash Flow | -0.43 | -10.25 | 11.96 | -0.9 | 1.32 | - |
Financing Activities
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Short-Term Debt Issued | - | - | - | - | - | 0.89 |
Total Debt Issued | - | - | - | - | - | 0.89 |
Short-Term Debt Repaid | - | - | - | -2.25 | -0.06 | - |
Long-Term Debt Repaid | - | -2.99 | -2.43 | - | - | - |
Total Debt Repaid | -3.07 | -2.99 | -2.43 | -2.25 | -0.06 | - |
Net Debt Issued (Repaid) | -3.07 | -2.99 | -2.43 | -2.25 | -0.06 | 0.89 |
Issuance of Common Stock | - | - | - | 33.48 | 34.05 | - |
Other Financing Activities | - | - | -34.1 | -34.05 | - | - |
Financing Cash Flow | -3.07 | -2.99 | -36.53 | -2.82 | 33.99 | 0.89 |
Net Cash Flow
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Miscellaneous Cash Flow Adjustments | 1.03 | - | - | - | 0 | - |
Net Cash Flow | -0.13 | 8 | -8.8 | -24.56 | 34.23 | -0.46 |
Free Cash Flow
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Free Cash Flow | 2.01 | 10.99 | 15.76 | -21.74 | -1.08 | -1.35 |
Free Cash Flow Growth | -87.27% | -30.26% | - | - | - | - |
Free Cash Flow Margin | 2.97% | 19.04% | 45.33% | -181.58% | -100.73% | -61.70% |
Free Cash Flow Per Share | 0.04 | 0.19 | 0.27 | -0.38 | -0.04 | -0.06 |
Levered Free Cash Flow | 16.52 | 24.07 | 25.95 | -23.31 | -1.17 | -1.44 |
Unlevered Free Cash Flow | 16.9 | 24.53 | 26.65 | -23.29 | -1.1 | -1.39 |
Additional Metrics
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Change in Working Capital | -20.33 | 11.74 | 24.29 | -22.53 | -1.6 | -2.2 |